148 related articles for article (PubMed ID: 1979622)
1. Effect of nipradilol on myocardial energy metabolism in the dog ischaemic heart.
Hayase N; Chiba K; Ichihara K; Inagaki S; Abiko Y
J Pharm Pharmacol; 1990 Jun; 42(6):419-22. PubMed ID: 1979622
[TBL] [Abstract][Full Text] [Related]
2. Participation of the vasodilating property of nipradilol in improving ischemic derangement of myocardial energy metabolism.
Higuchi M
J Cardiovasc Pharmacol; 1989 Jul; 14(1):157-65. PubMed ID: 2475707
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of nipradilol (K-351) on acute myocardial ischemia. Study of the relationship between regional myocardial blood flow and energy metabolism.
Okamoto Y; Matsubara T; Iyeda N; Miyajima K; Iida K; Nishida T; Kobayashi S; Kakinuma Y; Itoh K; Hibi N
Jpn J Pharmacol; 1990 Feb; 52(2):371-7. PubMed ID: 1968987
[TBL] [Abstract][Full Text] [Related]
4. Effects of nipradilol, a new beta-adrenoceptor blocking agent with vasodilating properties, on transmural energy metabolism in the underperfused canine heart.
Higuchi M; Asakawa T
Jpn J Pharmacol; 1987 Jun; 44(2):145-53. PubMed ID: 2888916
[TBL] [Abstract][Full Text] [Related]
5. Effect of nadolol, a beta-adrenoceptor blocking agent, on myocardial metabolism in the dog ischaemic heart.
Ichihara K; Abiko Y
J Pharm Pharmacol; 1987 Aug; 39(8):604-8. PubMed ID: 2888850
[TBL] [Abstract][Full Text] [Related]
6. Nipradilol, a beta-adrenoceptor antagonist having a vasodilatory action, attenuates myocardial acidosis induced by coronary artery occlusion in dogs.
Hino T; Hayase N; Chiba K; Ichihara K; Abiko Y
Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):373-8. PubMed ID: 2568518
[TBL] [Abstract][Full Text] [Related]
7. Effects of nipradilol on myocardial ischaemia produced by coronary stenosis in dogs.
Noguchi K; Sakanashi M
Br J Pharmacol; 1987 Jun; 91(2):411-9. PubMed ID: 2886171
[TBL] [Abstract][Full Text] [Related]
8. Effects of bunazosin, a selective alpha 1-adrenergic blocking agent, on myocardial energy metabolism in ischemic dog heart.
Yoshida R; Ichihara K; Abiko Y
Jpn J Pharmacol; 1990 Aug; 53(4):435-41. PubMed ID: 1976843
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of nipradilol, a beta-adrenoceptor blocker with vasodilating properties.
Fujii M; Shirasawa Y; Kondo S; Sawanobori K; Nakamura M
Jpn Heart J; 1986 Mar; 27(2):233-50. PubMed ID: 2873263
[TBL] [Abstract][Full Text] [Related]
10. Effects of nicorandil and nipradilol on ischemic myocardium in perfused rat heart.
Haneda T; Ichihara K; Onodera S
Eur J Pharmacol; 1989 Mar; 162(1):81-7. PubMed ID: 2524396
[TBL] [Abstract][Full Text] [Related]
11. Nipradilol depresses cardiac contractility and O2 consumption without decreasing coronary resistance in dogs.
Zhao DD; Namba T; Araki J; Ishioka K; Takaki M; Suga H
Acta Med Okayama; 1993 Feb; 47(1):29-33. PubMed ID: 8096354
[TBL] [Abstract][Full Text] [Related]
12. Effects of LP-805, a newly developed vasodilator, on myocardial metabolism in ischaemic dog hearts.
Ichihara K; Morimoto T; Tsujitani M; Abiko Y
J Pharm Pharmacol; 1993 Feb; 45(2):131-6. PubMed ID: 8095528
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of ischaemia-induced regional myocardial acidosis by bevantolol, a beta 1-adrenoceptor antagonist, in dogs.
Hino T; Sakai K; Ichihara K; Abiko Y
Pharmacol Toxicol; 1989 Apr; 64(4):324-8. PubMed ID: 2568629
[TBL] [Abstract][Full Text] [Related]
14. Effects of sevoflurane on ischaemic myocardium in dogs.
Takahata O; Ichihara K; Ogawa H
Acta Anaesthesiol Scand; 1995 May; 39(4):449-56. PubMed ID: 7676777
[TBL] [Abstract][Full Text] [Related]
15. Prevention of ventricular fibrillation by metoprolol in a pig model of acute myocardial ischaemia: absence of a major arrhythmogenic role for cyclic AMP.
Muller CA; Opie LH; Hamm CW; Peisach M; Gihwala D
J Mol Cell Cardiol; 1986 Apr; 18(4):375-87. PubMed ID: 3012099
[TBL] [Abstract][Full Text] [Related]
16. The inhibitory effect of bevantolol on the accumulation of non-esterified fatty acids during ischaemia in the dog heart in situ.
Miura I; Nasa Y; Ichihara K; Abiko Y
Clin Exp Pharmacol Physiol; 1991 Apr; 18(4):259-62. PubMed ID: 1676940
[TBL] [Abstract][Full Text] [Related]
17. Influence of propranolol isomers and atenolol on myocardial cyclic AMP, high energy phosphates and vulnerability to fibrillation after coronary artery ligation in the isolated rat heart.
Lubbe WF; Muller CA; Worthington M; McFadyen EL; Opie LH
Cardiovasc Res; 1981 Dec; 15(12):690-9. PubMed ID: 6275992
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effect of metoprolol on energy metabolism in the ischaemic myocardium in relation to regional myocardial blood flow.
Nanki M; Itoh K; Matsubara T; Nishimura K; Kambe T; Sugiyama S; Ozawa T; Sakamoto N
Cardiovasc Res; 1987 Sep; 21(9):660-7. PubMed ID: 3446370
[TBL] [Abstract][Full Text] [Related]
19. Effects of glutamic acid on cardiac function and energy metabolism of rat heart during ischaemia and reperfusion.
Choong YS; Gavin JB; Armiger LC
J Mol Cell Cardiol; 1988 Nov; 20(11):1043-51. PubMed ID: 2907055
[TBL] [Abstract][Full Text] [Related]
20. Metabolic profile of beta-adrenoceptor-blocking action of befunolol.
Maruyama Y; Awaji T; Inoue M; Takeo S
Arch Int Pharmacodyn Ther; 1991; 311():73-88. PubMed ID: 1686392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
